However, addition of exogenous SHH to the esophageal adenocarcinoma cell lines increased GLI activity and the combination of vismodegib and everolimus (mTOR antagonist) suppressed tumor growth more than either drug alone in vivo [194]. This evidence concerns the gene GLI1 and esophageal adenocarcinoma.